
AVIENCE BIOMEDICALS (AVIENCE) Share Price Falls 9.01% Today; Valuation Stays In Focus
Updated: 1 Oct 2026 • 9:25 am
Posted by:

AVIENCE BIOMEDICALS Share Price is trading lower today after a sharp decline of 9.01% to Rs 327.30, with the company’s market capitalisation at Rs 198.37 Cr. The move makes AVIENCE BIOMEDICALS Share Price one of the key stock news items in Healthcare this morning, especially because the stock is a Micro Cap and the change came without a company-specific catalyst being established. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. For investors tracking AVIENCE BIOMEDICALS Share Price Today, the focus now shifts to the day’s price action, valuation ratios, and sector comparison rather than any unsupported explanation for the decline. Univest data shows a clean intraday decline, and the stock remains relevant for anyone following AVIENCE BIOMEDICALS Share Price Live, AVIENCE BIOMEDICALS Share Price Update and AVIENCE BIOMEDICALS Stock News.
From a market-news standpoint, AVIENCE BIOMEDICALS Share Price is noteworthy because the fall comes while the broader discussion around the company still centres on fundamental analysis, Healthcare peer positioning and market capitalisation. Univest data points to a company that is small in size but rich in profitability ratios, which is why AVIENCE BIOMEDICALS Share Price continues to attract attention even on a weak day. The combination of a lower share price, a Micro Cap profile and a premium-to-median valuation profile gives AVIENCE BIOMEDICALS Share Price a distinctly stock-analysis angle today. For readers searching Why Is AVIENCE BIOMEDICALS Falling Today, the verified answer is to the price event itself, not an unverified catalyst.
AVIENCE BIOMEDICALS (AVIENCE) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 327.3 |
| Previous Close | Rs 359.7 |
| Today's Move | -Rs 32.40 (-9.01%) |
| Open | Rs 340.05 |
| High | Rs 340.05 |
| Low | Rs 326 |
| Market Capitalisation | Rs 198.37 crore |
| Market Cap Category | Micro Cap |
AVIENCE BIOMEDICALS Share Price opened at Rs 340.05, matched the day high at Rs 340.05 and moved down to a low of Rs 326 before last trading at Rs 327.30. That compares with the previous close of Rs 359.7, so the stock is down Rs 32.4 on the day. The decline of 9.01% places AVIENCE BIOMEDICALS Share Price firmly among the day’s stronger fallers, even though the move was confined to a narrow intraday band after the open. The current market capitalisation of Rs 198.37 Cr places AVIENCE BIOMEDICALS Share Price in the Micro Cap category, which is important context when reading today’s price action. In short, AVIENCE BIOMEDICALS Share Price Today reflects a sharp gap from the prior close, a lower intraday low, and a trade that has stayed below the opening level throughout the morning session. That sets up the next question: what do the fundamentals say about AVIENCE BIOMEDICALS Share Price?
AVIENCE BIOMEDICALS (AVIENCE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 198.37 crore |
| P/E Ratio | 22.54x |
| P/B Ratio | 8.14x |
| ROE | 49.9% |
| ROCE | 34.16% |
| EPS | Rs 15.96 |
| Book Value Per Share | Rs 44.18 |
| Dividend Yield | 0% |
AVIENCE BIOMEDICALS (AVIENCE) fundamental metrics show P/E 22.54x, P/B 8.14x, ROE 49.9%, ROCE 34.16%. These figures provide context only and are not a buy or sell signal.
AVIENCE BIOMEDICALS has a market capitalisation of Rs 198.37 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 22.54x, P/B at 8.14x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 49.9% and ROCE of 34.16%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.96, book value per share of Rs 44.18, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 34.12x, median ROE of 13.4%, median ROCE of 14.55%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Medical Equipment/Supplies/Accessories |
| Benchmark Scope | same industry |
| Company P/E Ratio | 22.54x |
| Benchmark Median P/E | 34.12x |
| Benchmark Average P/E | 91.5x |
| Benchmark P/E Range | 7.83x to 1,027.7x |
| Company P/B Ratio | 8.14x |
| Benchmark Median P/B | 3.75x |
| Benchmark Average P/B | 4.36x |
| Company ROE | 49.9% |
| Benchmark Median ROE | 13.4% |
| Benchmark Average ROE | 16.07% |
| Company ROCE | 34.16% |
| Benchmark Median ROCE | 14.55% |
| Benchmark Average ROCE | 17.26% |
| Company Market Capitalisation | Rs 198.37 crore |
| Benchmark Median Market Cap | Rs 188.59 crore |
| Benchmark Average Market Cap | Rs 6,432.8 crore |
AVIENCE BIOMEDICALS (AVIENCE) operates in the Healthcare sector, within the Medical Equipment/Supplies/Accessories industry.
AVIENCE BIOMEDICALS (AVIENCE) has a P/E ratio of 22.54x, which is below the benchmark median of 34.12x, a difference of -33.94%. On its own, the P/E gap is a valuation reference point, not a trading call.
AVIENCE BIOMEDICALS (AVIENCE) has a ROE of 49.9%, which is above the benchmark median of 13.4%, a difference of +272.39%. AVIENCE BIOMEDICALS (AVIENCE) has a ROCE of 34.16%, which is above the benchmark median of 14.55%, a difference of +134.78%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| LENSKART SOLUTIONS | LENSKART | 1,17,229.24 | 182.28 | 13.36 | 6.85 | 12.55 |
| Poly Medicure | POLYMED | 16,633.42 | 53.88 | 5.33 | 10.94 | 14.05 |
| Q-LINE BIOTECH | QLINE | 1,569.4 | 28.51 | 6.27 | 25.55 | 22.23 |
| 3B Blackbio Dx | 3BBLACKBIO | 1,394.77 | 26.17 | 4.36 | 20.22 | 25.9 |
| LAXMI DENTAL | LAXMIDENTL | 1,057.39 | 34.12 | 4.29 | 11.95 | 13.29 |
AVIENCE BIOMEDICALS (AVIENCE) has a P/E ratio of 22.54x compared with the displayed peer median of 34.12x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 49.9% compares with a peer median of 11.95% across the companies shown in the table. ROCE stood at 34.16% versus the displayed peer median of 14.05%, providing a capital-efficiency comparison. AVIENCE BIOMEDICALS (AVIENCE) has a market capitalisation of Rs 198.37 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching AVIENCE BIOMEDICALS
- AVIENCE BIOMEDICALS Share Price fell 9.01% today, making the move important in same-day market monitoring.
- AVIENCE BIOMEDICALS Share Price remains a Micro Cap, so even a modest move can reshape the day’s price action.
- AVIENCE BIOMEDICALS Share Price has strong ROE and ROCE figures relative to the industry benchmark.
- AVIENCE BIOMEDICALS Share Price trades at a P/E below the industry median, while P/B stays above the sector centre.
- AVIENCE BIOMEDICALS Share Price is part of Healthcare stock news and peer comparison screens on Univest.
About AVIENCE BIOMEDICALS
AVIENCE BIOMEDICALS operates in the Healthcare sector and the Medical Equipment/Supplies/Accessories industry. The business context places AVIENCE BIOMEDICALS Share Price within a segment where company results are often judged by return ratios, valuation multiples and how efficiently capital is used. Based on the latest Univest figures, the company’s market position is that of a Micro Cap with a market capitalisation near the centre of its industry peer set. That framing matters for AVIENCE BIOMEDICALS Share Price because investors often compare smaller Healthcare names on profitability, book value and relative valuation rather than on size alone.
Track AVIENCE BIOMEDICALS Share Price on Univest
Use Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track AVIENCE BIOMEDICALS Share Price on Univest for live updates, key ratios, 52-week levels, market capitalisation, sector context and company news. Univest also brings together AVIENCE BIOMEDICALS Stock News, AVIENCE BIOMEDICALS Share Price Today and AVIENCE BIOMEDICALS Fundamental Analysis in one place for faster reading. If you are monitoring AVIENCE BIOMEDICALS Share Price Update or AVIENCE BIOMEDICALS Latest News, the platform helps you follow the stock with structured context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did AVIENCE BIOMEDICALS Share Price fall today?
Ans. AVIENCE BIOMEDICALS Share Price fell 9.01% to Rs 327.30, but no company-specific catalyst is established. The verified facts point to the price event itself, along with a lower intraday range and a Micro Cap market capitalisation.
What is AVIENCE BIOMEDICALS Share Price today?
Ans. AVIENCE BIOMEDICALS Share Price is Rs 327.30, compared with a previous close of Rs 359.7. The stock opened at Rs 340.05 and traded as low as Rs 326 during the morning session.
How much did AVIENCE BIOMEDICALS Share Price decline?
Ans. AVIENCE BIOMEDICALS Share Price declined by Rs 32.4, which works out to 9.01% on the day. That makes the move a clear price fall rather than a small routine fluctuation in the session.
What is the market capitalisation of AVIENCE BIOMEDICALS?
Ans. AVIENCE BIOMEDICALS Share Price corresponds to a market capitalisation of Rs 198.37 Cr. Univest classifies the company as a Micro Cap, which is useful context when reading the day’s decline and peer comparison.
What are the key valuation ratios for AVIENCE BIOMEDICALS Share Price?
Ans. AVIENCE BIOMEDICALS Share Price has a P/E of 22.54 and a P/B of 8.14. In the same industry set, the P/E sits below the median, while the P/B is above the industry centre.
How do profitability ratios compare for AVIENCE BIOMEDICALS Share Price?
Ans. AVIENCE BIOMEDICALS Share Price shows ROE of 49.9% and ROCE of 34.16%. Both are well above the sector median and average in the same industry benchmark, which is a notable part of the stock’s profile.
What do EPS and book value mean for AVIENCE BIOMEDICALS Share Price?
Ans. AVIENCE BIOMEDICALS Share Price has EPS of Rs 15.96 and book value of Rs 44.18. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.
Should investors track AVIENCE BIOMEDICALS Share Price on Univest?
Ans. Yes, AVIENCE BIOMEDICALS Share Price is worth tracking on Univest because the stock combines a sharp daily decline, strong returns ratios and a valuation profile that sits differently from its Healthcare peers.
Recent Articles

Kalyan Jewellers Share Price Rally: Stock Gains About 42% in 11 Sessions After Rs 427 Crore Q2 Profit, Hits Near Two-Year High and Trades at Rs 708.15 on 16 November 2026 as UBS and Jefferies Raise Targets
16 November 2026

Tata Motors PV vs Eicher Motors After Q2: TMPV Falls 8.7% to Rs 262 on a Rs 5,451 Crore Loss and JLR Guidance Cut While Eicher Posts Record Revenue and a 15% Profit Rise
16 November 2026

Belrise Industries Share Price Jumps 9% to Rs 235 After Q2 PAT Rises 25%: Fresh H-One India Merger, Electronics Entry and Aerospace Orders Drive a Spike of up to 12.4% on 16 November 2026
16 November 2026

Sebi Trading Terminal Rules: What Biometrics, Geotagging and MAC Address Mapping Could Mean for Brokers, Authorised Persons and Traders as the Regulator Targets Terminal Misuse
16 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Kalyan Jewellers Share Price Rally: Stock Gains About 42% in 11 Sessions After Rs 427 Crore Q2 Profit, Hits Near Two-Year High and Trades at Rs 708.15 on 16 November 2026 as UBS and Jefferies Raise Targets
Tata Motors PV vs Eicher Motors After Q2: TMPV Falls 8.7% to Rs 262 on a Rs 5,451 Crore Loss and JLR Guidance Cut While Eicher Posts Record Revenue and a 15% Profit Rise
Belrise Industries Share Price Jumps 9% to Rs 235 After Q2 PAT Rises 25%: Fresh H-One India Merger, Electronics Entry and Aerospace Orders Drive a Spike of up to 12.4% on 16 November 2026
Sebi Trading Terminal Rules: What Biometrics, Geotagging and MAC Address Mapping Could Mean for Brokers, Authorised Persons and Traders as the Regulator Targets Terminal Misuse
Ola Electric vs Ather Energy After Q2: Ather's Rs 1.26 Crore Profit and 63% Revenue Growth Against Ola's Rs 362 Crore Loss and 39% Revenue Fall, and What the Share Prices Imply on 16 November 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





